5SE3
Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyridine-4-carboxamide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X10SA |
Synchrotron site | SLS |
Beamline | X10SA |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2011-02-07 |
Detector | PSI PILATUS 6M |
Wavelength(s) | 1.000000 |
Spacegroup name | H 3 |
Unit cell lengths | 135.370, 135.370, 235.253 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 43.540 - 2.140 |
R-factor | 0.1821 |
Rwork | 0.180 |
R-free | 0.22590 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | inhouse model |
RMSD bond length | 0.010 |
RMSD bond angle | 1.646 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0258) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 43.540 | 43.540 | 2.200 |
High resolution limit [Å] | 2.140 | 9.570 | 2.140 |
Rmerge | 0.098 | 0.020 | 1.116 |
Rmeas | 0.109 | 0.023 | 1.236 |
Total number of observations | 469203 | ||
Number of reflections | 88671 | 989 | 6572 |
<I/σ(I)> | 12.82 | 65.53 | 1.44 |
Completeness [%] | 100.0 | 98.8 | 99.9 |
Redundancy | 5.292 | 5.496 | 5.405 |
CC(1/2) | 0.998 | 0.999 | 0.551 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 295 | 5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2 |